Advertisement

Topics

CDI Corp. Company Profile

21:34 EDT 19th June 2018 | BioPortfolio


News Articles [66 Associated News Articles listed on BioPortfolio]

Korea Investment CORP Boosts Stake in Mylan

Korea Investment CORP grew its position in Mylan by 462.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 736,474 shar...

GTX Corp Announces New GPS Take-Along World Tracker for $89.00

LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an IoT platform and global provider of GPS tracking and monitoring wearable and wandering assistive technology, announced toda...

GTX Corp First Quarter 2018 Summary

Revenues increased 76%, Subscribers increased 79%, G&A decreased 17% LOS ANGELES, May 16, 2018 (GLOBE NEWSWIRE) -- GTX Corp. (OTCQB:GTXO), an IoT platform and leading provider of personal loc...

Emblem Corp. Reports 2018 First Quarter Results

Strengthened team, new products, and key distribution partnerships driving demand NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, May 2...

GTX Corp and Veristride Presenting Biometric Insoles at CES 2018

LOS ANGELES, Jan. 04, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive technology business...

Emblem Corp. Issues President’s Letter to Shareholders

TORONTO, March 20, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) ("Emblem" or the "Corporation") provides a Letter to its Shareholders as follows: Spring is upon us, and Emblem is ...

Scythian Biosciences Announces Name Change to SOL Global Investments Corp.

TORONTO, June 05, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that the Compa...

Scythian Biosciences Corp. Announces Proposed Up To 8 for 1 Stock Split

TORONTO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) announces that its Board of Directors has app...

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Companies [39 Associated Companies listed on BioPortfolio]

ATLANTIS DRUG CORP

Nil

NORLOFF COMPUTER CORP

Nil

Precision Engineered Products LLC

SINOCHEM JIANGSU SUZHOU I/E CORP.

SINOCHEM JIANGSU SUZHOU I/E CORP. ESTABLISHED IN 1988, IS A SUBSIDIARY OF SINOCHEM AND A STATE-OWNED FOREIGH TRADE ENTERPRISE AUTHORISED BY THE CHINESE MINISTRY OF FOREIGH TRADE AND ECONOMIC C...

AmSurg Corp.

AMSURG Corp. acquires, develops and operates ambulatory surgery centers in partnership with physician practice groups throughout the United States. At March 31, 2014, AMSURG owned...

More Information about "CDI Corp." on BioPortfolio

We have published hundreds of CDI Corp. news stories on BioPortfolio along with dozens of CDI Corp. Clinical Trials and PubMed Articles about CDI Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CDI Corp. Companies in our database. You can also find out about relevant CDI Corp. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record